Search
01/05/2026
Multidisciplinary clinical practice guidelines for the management of metabolic fatty liver disease
Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Cañones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA, Calleja, JL. Multidisciplinary clinical practice guidelines for the management of metabolic fatty liver disease. Gastroenterologia y Hepatologia. 2026; 49(5)DOI:10.1016/j.gastrohep.2025.502640. PMID:. IF:1.900(Q3/7D).
01/05/2026
Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic-Related Diseases Diabetes, Prediabetes, and Obesity
Diamantopoulos, L, Kalligeros, M, Isaacs, SD, Mauricio, D. Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic-Related Diseases Diabetes, Prediabetes, and Obesity. Clinics in Liver Disease. 2026; 30(2)DOI:10.1016/j.cld.2025.12.001. PMID:42142893. IF:4.100(Q1/3D).
01/05/2026
The echo of a question, ten years later: Letter to Amanda and Jesus
Milad, C, Mesa, A. The echo of a question, ten years later: Letter to Amanda and Jesus. Endocrinologia Diabetes y Nutricion. 2026; 73(5)DOI:10.1016/j.endien.2026.501772. PMID:41887969. IF:1.800(Q3/8D).
01/05/2026
Serological responses COVID-19 vaccination: a potential biomarker to predict liver-related complications in patients with compensated advanced liver disease (cACLD)
Hong, CZ, Ballester, MP, Perricone, G, Merli, M, Buti, M, Panero, JLC, Soriano, G, Toniutto, P, Ampuero, J, Russo, FP, Sacerdoti, D, Coenraad, M, Berenguer, M, Piano, S, Sangiovanni, A, Albillos, A, Gander, A, Patel, VC, Caraceni, P, Wright, G, Iruzubieta, P, Andrade, RJ, Garcia-Samaniego, FJ, Verhelst, X, Uson, E, Sanchez-Garrido, C, Mehta, G, Jalan, R. Serological responses COVID-19 vaccination: a potential biomarker to predict liver-related complications in patients with compensated advanced liver disease (cACLD). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Assessment of cardiometabolic comorbidities and the impact of glycemic and weight control on liver stiffness in advanced metabolic dysfunction-associated steatotic liver disease
El Maimouni, C, Jiménez-Massip, A, Canillas, L, Serra, I, Vergara, M, Morillas, RM, Poca, M, Broquetas, T, Rodríguez-Castellano, A, Munoz, EE, Soria, A, Pages, L, Carrión, J, Casas, M, Ardevol, A, Rojo, D, Alonso, N, Julián, MT, Bassegoda, O, Gines, P, Pericàs, JM, Graupera, I. Assessment of cardiometabolic comorbidities and the impact of glycemic and weight control on liver stiffness in advanced metabolic dysfunction-associated steatotic liver disease. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2026
Treatment with albumin improves circulatory function in patients with cirrhosis and hypovolemic hyponatremia: insights from a randomized controlled trial, the ALBUCAT study
Juanola, A, Moreta, MJ, Solé, C, Perez-Guasch, M, Gratacós-Ginès, J, Soria, A, Cuyàs, B, Martin-Llahi, M, Ma, A, Pompili, E, Fernández, I, Amorós, M, Cruceta, A, Diestro, S, Domenech, G, Rios, J, Sánchez, J, Fabrellas, N, Graupera, I, Pose, E, Ginès, P. Treatment with albumin improves circulatory function in patients with cirrhosis and hypovolemic hyponatremia: insights from a randomized controlled trial, the ALBUCAT study. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).